FeesSafety
Pluang+

CACI wins $108M Air Force contract to modernize financial systems and boost efficiency.

Market News
03 Nov 2026, 15:15 WIB
PRNewsWire
View Source
Bullish
CACI wins $108M Air Force contract to modernize financial systems and boost efficiency.

CACI International secured a $108 million, five-year contract from the U.S. Air Force to modernize the Defense Enterprise Accounting and Management System (DEAMS). This upgrade aims to enhance financial transparency, operational efficiency, and mission readiness by enabling faster, data-driven decisions and improved global financial operations. CACI will apply advanced technologies like Agile development, automated testing, and cloud operations to support the Air Force's financial modernization efforts and maintain strong cybersecurity. This contract builds on DEAMS' recent audit success and aims to further streamline financial processes for better support of military operations.

CACI International's contract with the U.S. Air Force provides context for the technology sector's performance on Pluang. For readers following Technology-sector US stocks, here is Pluang's market snapshot as of Nov 03, 2026 19:43 WIB: out of 150 stocks, 73 rose and 76 fell. Notable movers include MU at USD 864.17 (+3.67%), AMAT at USD 387.99 (+3.59%), and MCHP at USD 78.83 (+3.57%).

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
1 hour ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
1 hour ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
1 hour ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
2 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App